Nouf Al-Fadel1, Mansour A Mahmoud2, Rabih Dabliz3, Osama Tabbara4, Hisham Aljadhey2. 1. Vigilance and Benefit-Risk Assessment Executive Directorate, Saudi Food and Drug Authority, Riyadh, Saudi Arabia. 2. Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. 3. Quality & Medication Safety Services, Cleveland Clinic Abu Dhabi (CCAD), Abu Dhabi, United Arab Emirates. 4. Department of Pharmacy Services, CCAD, Abu Dhabi, United Arab Emirates.
Abstract
OBJECTIVES: To evaluate implementation of safety standards of compounded sterile preparations in different hospitals. METHODS: This cross-sectional study included 124 hospitals from 19 countries. A survey was developed based on the guidelines and safety practices of the Institute for Safe Medication Practices (ISMP) for sterile preparations compounding, and was sent to the members of the Intravenous and Parenteral Nutrition experts' network (IV PN experts' network) in the Gulf region and beyond using SurveyMonkey software. RESULTS: 124 pharmacists were invited to participate in this study. Only 39 (31.5%) pharmacists from seven countries responded: 16 (41%) of the participants were pharmacy supervisors, and 23 (59%) had >10 years of work experience. However, a majority, 27 (69%), of the respondents were from Saudi Arabia. Written policies and procedures for sterile preparations compounding were available in 37 (95%) hospitals. The concentrated electrolytes were removed from all patient care areas in 28 (72%) hospitals, and 30 (77%) hospitals clearly labelled those as high-alert medications. The use of advanced technologies, such as bar code verification or IV robotics, for compounding sterile preparations were not implemented in 27 (69%) hospitals. CONCLUSIONS: Minimum standards and best practice recommendations to ensure safety of sterile preparation compounding were implemented in many hospitals of different countries. However, advanced technologies were not implemented by the majority of the hospitals.
OBJECTIVES: To evaluate implementation of safety standards of compounded sterile preparations in different hospitals. METHODS: This cross-sectional study included 124 hospitals from 19 countries. A survey was developed based on the guidelines and safety practices of the Institute for Safe Medication Practices (ISMP) for sterile preparations compounding, and was sent to the members of the Intravenous and Parenteral Nutrition experts' network (IV PN experts' network) in the Gulf region and beyond using SurveyMonkey software. RESULTS: 124 pharmacists were invited to participate in this study. Only 39 (31.5%) pharmacists from seven countries responded: 16 (41%) of the participants were pharmacy supervisors, and 23 (59%) had >10 years of work experience. However, a majority, 27 (69%), of the respondents were from Saudi Arabia. Written policies and procedures for sterile preparations compounding were available in 37 (95%) hospitals. The concentrated electrolytes were removed from all patient care areas in 28 (72%) hospitals, and 30 (77%) hospitals clearly labelled those as high-alert medications. The use of advanced technologies, such as bar code verification or IV robotics, for compounding sterile preparations were not implemented in 27 (69%) hospitals. CONCLUSIONS: Minimum standards and best practice recommendations to ensure safety of sterile preparation compounding were implemented in many hospitals of different countries. However, advanced technologies were not implemented by the majority of the hospitals.
Entities:
Keywords:
Compounded sterile preparations; Cross-sectional study; Institute for Safe Medication Practice (ISMP); Intravenous and Parenteral Nutrition (IV PN ) experts network; Saudi Arabia
Authors: Basit Chaudhry; Jerome Wang; Shinyi Wu; Margaret Maglione; Walter Mojica; Elizabeth Roth; Sally C Morton; Paul G Shekelle Journal: Ann Intern Med Date: 2006-04-11 Impact factor: 25.391
Authors: Eric G Poon; Jennifer L Cina; William Churchill; Nirali Patel; Erica Featherstone; Jeffrey M Rothschild; Carol A Keohane; Anthony D Whittemore; David W Bates; Tejal K Gandhi Journal: Ann Intern Med Date: 2006-09-19 Impact factor: 25.391
Authors: Dejana Selenic; Douglas R Dodson; Bette Jensen; Matthew J Arduino; Adelisa Panlilio; Lennox K Archibald Journal: Am J Health Syst Pharm Date: 2003-07-15 Impact factor: 2.637